ArticleEuropean radiology2017
Feasibility of a 2
Article in European radiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 41 citations in OpenAlex.
- Comparison of analgesic techniques in MRI-guided in-bore prostate biopsy.European radiology · 2019Trial
- Flexible intervention workflow for MRI guided robotic prostate seed brachytherapy.Journal of applied clinical medical physics · 2026Article
- Clinical validation of a Novel Robotic Device for MR-Guided Prostate Biopsy: Initial Patient Experience.Journal of medical robotics research · 2026Article
- Real-Time Deep-Learning Image Reconstruction and Instrument Tracking in MR-Guided Biopsies.Journal of magnetic resonance imaging : JMRI · 2026Article
- Deep learning-based temporal MR image reconstruction for accelerated interventional imaging during in-bore biopsies.Journal of medical imaging (Bellingham, Wash.) · 2025Article
- Design and evaluation of a pneumatic actuation unit for a wasp-inspired self-propelled needle.PloS one · 2024Article
- Robot-Assisted Magnetic Resonance Imaging-Targeted versus Systematic Prostate Biopsy; Systematic Review and Meta-Analysis.Cancers · 2023Review
- Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy.European urology open science · 2022Article
- Clinical implementation of pre-biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancer.BJU international · 2022Article
- MR Imaging in Real Time Guiding of Therapies in Prostate Cancer.Life (Basel, Switzerland) · 2022Review
- Techniques and Outcomes of MRI-TRUS Fusion Prostate Biopsy.Current urology reports · 2021Review
- Robotic-assisted transrectal MRI-guided biopsy. Technical feasibility and role in the current diagnosis of prostate cancer: an initial single-center experience.Abdominal radiology (New York) · 2020Article
- In-bore biopsies of the prostate assisted by a remote-controlled manipulator at 1.5 T.Magma (New York, N.Y.) · 2019Article
- GantryMate: A Modular MR-Compatible Assistance System for MR-Guided Needle Interventions.Tomography (Ann Arbor, Mich.) · 2019Article
- Fast 3-T MR-guided transrectal prostate biopsy using an in-room tablet device for needle guide alignment: a feasibility study.European radiology · 2018Article
- Stormram 4: An MR Safe Robotic System for Breast Biopsy.Annals of biomedical engineering · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo assess the feasibility of a 2
methodsThis prospective phase I study was approved by the local ethical committee and written informed consent was obtained from each patient. Twenty patients with ≥1 cancer suspicious region (CSR) with a PI-RADS score of ≥3 detected on the diagnostic multi-parametric MRI and no prior prostate treatment underwent MR-guided biopsy with the aid of the RCM. Complications were classified according to the modified Clavien system for reporting surgical complications. For evaluation of the workflow, procedure- and manipulation times were recorded.
resultsAll CSR's (n=20) were reachable with the MR-compatible RCM and the cancer detection rate was 70 %. The median procedure time was 36:44 minutes (range, 23 - 61 minutes) and the median manipulation time for needle guide movement was 5:48 minutes (range, 1:15 - 18:35 minutes). Two Clavien grade 1 complications were reported.
conclusionsIt is feasible and safe to perform transrectal MR-guided prostate biopsy using a MR-compatible RCM as an aid. It is a fast and efficient way to biopsy suspicious prostate lesions with a minimum number of biopsies per patient. KEY POINTS: • It is feasible to perform transrectal prostate biopsy using a MR-compatible RCM. • Using a RCM for MR-guided biopsy is safe, fast, and efficient. • All cancer suspicious regions were reachable with the RCM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.